Bcl-2/Bcl-x(L) inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death

Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignant disease that is resistant to various chemotherapeutic agents and commonly relapses. Efficient elimination of metastasized PDA is critical for a positive post-surgical treatment outcome. The present study analyzed the effect of the B-c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Kasai, Shuya, Sasaki, Takuya, Watanabe, Ayano, Nishiya, Masao, Yasuhira, Shinji, Shibazaki, Masahiko, Maesawa, Chihaya
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494882/
https://ncbi.nlm.nih.gov/pubmed/28693250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6211
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky